Trial intelligence / Profile preview

Genistein with FOLFOX/Avastin in metastatic colorectal cancer

NCT01985763Phase 2Completed

Sponsor
Sofya Pintova
Start
Nov 2013
Primary completion
Jan 2017
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 2 trial of genistein in metastatic colorectal cancer (mCRC), sponsored by Sofya Pintova. Started Nov 2013; status: completed.

02

Drugs

genistein
03

Conditions

metastatic colorectal cancer (mCRC)

Beyond the preview

Go deeper on NCT01985763.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01985763.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call